Punit Dhillon insider trades
Open-market stock purchases and sales by Punit Dhillon, Chief Executive Officer at Skye Bioscience, Inc, from SEC Form 4 filings since Mar 1, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 7, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | — |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $154K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $723K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $22.1K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $405K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $7.6K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $179K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $400K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $3.3M |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $76.9K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $1.8M |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $5.5K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $31.5K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | $13.3K |
| Mar 31, 2026 | SKYE Skye Bioscience, Inc | Sold (not open market) | $75.6K |
| Feb 6, 2026 | SKYE Skye Bioscience, Inc | Bought (not open market) | — |
Companies traded
- SKYE Skye Bioscience, Inc: 2 buys, 2 sales, last Aug 7, 2026
- ARTH Arch Therapeutics, Inc: other filings, last Nov 10, 2022
- EMBI Emerald Bioscience, Inc: other filings, last Aug 7, 2020
- ONCS ONCOSEC MEDICAL Inc: 13 buys, 23 sales, last Jan 2, 2019
- NMUS Nemus Bioscience, Inc: other filings, last Oct 10, 2018
- ONCS.OB ONCOSEC MEDICAL Inc: other filings, last Apr 25, 2012
- ONCS.D ONCOSEC MEDICAL Inc: 4 buys, last Mar 1, 2011